bioRxivSynthetic BiologyPreprint
Plant-based Production and Characterization of a Promising Fc-fusion Protein against Bone Mass Density Loss
Yongao XiongiD, Hiroto Hirano, Nancy E. LaneiD, Somen NandiiD, Karen A. McDonaldiD
Abstract
Microgravity-induced bone loss is a main obstacle for long term space missions as it is difficult to maintain bone mass when loading stimuli is reduced. With a typical bone mineral density loss of 1.5% per month of microgravity exposure, the chances for osteoporosis and fractures may endanger astronauts health. Parathyroid Hormone or PTH (1-34) is an FDA approved treatment for osteoporosis, and may reverse microgravity-induced bone loss. However, PTH proteins requires refrigeration, daily subcutaneous injection, and have a short shelf-life, limiting its use in a resource-limited environment, like space. In this study, PTH was produced in an Fc-fusion form via transient expression in plants, to improve the circulatory half-life which reduces dosing frequency and to simplify purification if needed. Plant-based expression is well-suited for space medicine application given its low resource consumption and short expression timeline. The PTH-Fc accumulation profile in plant was established with a peak expression on day 5 post infiltration of 373 {+/-} 59 mg/kg leaf fresh weight. Once the PTH-Fc was purified, the amino acid sequence and the binding affinity to its target, PTH 1 receptor (PTH1R), was determined utilizing biolayer interferometry (BLI). The binding affinity between PTH-Fc and PTH1R was 2.30 x 10-6 M, similar to the affinity between PTH (1-34) and PTH1R (2.31 x 10-6 M). Its function was also confirmed in a cell-based receptor stimulation assay, where PTH-Fc was able to stimulate the PTH1R producing cyclic adenosine monophosphate (cAMP) with an EC50 of (8.54 {+/-} 0.12) x 10-9 M, comparable to the EC50 from the PTH (1-34) of 1.49 x 10-8 M. These results suggest that plant recombinant PTH-Fc exhibits a similar potency compared to PTH. Furthermore, it can be produced rapidly at high levels with minimal resources and reagents, making it ideal for production in low resource environments such as space.
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Cellular mechanotransduction of human osteoblasts in microgravity
N. H. Wubshet, G. Cai, … A. P. Liu·bioRxiv·Mar 3, 2024
- A Single Multipurpose FSH-Blocking Therapeutic for Osteoporosis and Obesity
- PH domain and leucine rich repeat phosphatase 1 (Phlpp1) suppresses parathyroid hormone receptor 1 (Pth1r) expression and signaling during bone growth
Samantha R. Weaver, Earnest L. Taylor, … Jennifer J. Westendorf·Journal of Bone and Mineral ResearchPeer-reviewed·Dec 1, 2020
- Strontium treatment potentiates bone anabolic action of intermittent PTH in ovariectomized rats
Cyril Thouverey, Isabelle Badoud, Patrick Ammann·Calcified Tissue InternationalPeer-reviewed·Jul 28, 2026
- Microgravity enhances the phenotype of Arabidopsis zigzag-1 and reduces the Wortmannin-induced vacuole fusion in root cells
M. Wang, K. Danz, … M. Rojas-Pierce·bioRxiv·Apr 1, 2022
- PTH regulates osteogenesis and suppresses adipogenesis through Zfp 467 in a feed-forward, cyclic AMP-dependent manner
H. Liu, A. Wada, … C. J. Rosen·bioRxiv·Oct 10, 2022